Laboratorios Farmaceuticos Rovi's total assets for Q3 2024 were €877.85M, an increase of 2.39% from the previous quarter. ES:ROVI total liabilities were €319.66M for the fiscal quarter, a -14.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.